Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-18

Clinical Trial Update: Young Adults With Early-onset Obesity Treated With Semaglutide [Phase 4]

View source ↗

Summary

Phase 4 trial update on semaglutide for early-onset obesity in adolescents and young adults; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • semaglutide (semaglutide)

Snippet

Sponsor: Signe Torekov | Conditions: Obesity, Adolescent | Phase 4 | Status: RECRUITING